*Department of Pathology, Robert J Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH †Department of Pathology, Duke University Medical Center, Durham, NC ‡College of American Pathologists, Washington, DC §Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Adv Anat Pathol. 2017 Jul;24(4):222-225. doi: 10.1097/PAP.0000000000000156.
Health care reform has accelerated as the existing health care system undergoes continuing financial stress. Medicare's new value-based payment system, commonly referred to as MACRA, provides opportunities for physicians to participate in this new system in a variety of ways. However, many of the value-based adjustments are based on existing valuations of services through traditional mechanisms. To achieve appropriate valuation of pathologist's services in the new payment models, it is imperative that we continue to achieve proper valuation of services through the traditional mechanisms.
随着现有医疗体系持续面临财政压力，医疗改革正在加速。医疗保险的新基于价值的支付系统，通常被称为 MACRA，为医生提供了多种参与新系统的机会。然而，许多基于价值的调整都是基于通过传统机制对服务的现有评估。为了在新的支付模式中实现对病理学家服务的适当估值，我们必须通过传统机制继续实现对服务的适当估值。
